| 70.845 0.575 (0.82%) | 09-16 14:12 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 85.1  |
1-year : | 88.79 |
| Resists | First : | 72.86 |
Second : | 76.01 |
| Pivot price | 72.5 |
|||
| Supports | First : | 67.75 | Second : | 56.36 |
| MAs | MA(5) : | 70.55 |
MA(20) : | 72.54 |
| MA(100) : | 64.87 |
MA(250) : | 58.61 |
|
| MACD | MACD : | -0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 32 |
D(3) : | 27.8 |
| RSI | RSI(14): 47.4 |
|||
| 52-week | High : | 77.8 | Low : | 45.04 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ASH ] has closed above bottom band by 30.7%. Bollinger Bands are 13.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 70.97 - 71.47 | 71.47 - 71.86 |
| Low: | 68.06 - 68.59 | 68.59 - 69 |
| Close: | 69.58 - 70.4 | 70.4 - 71.03 |
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
Wed, 16 Sep 2026
Here's Why You Should Retain ASH Stock in Your Portfolio Now - ca.finance.yahoo.com
Wed, 16 Sep 2026
Here's Why You Should Retain ASH Stock in Your Portfolio Now - TradingView
Tue, 15 Sep 2026
Ashland edges higher on report bids due this month (ASH:NYSE) - Seeking Alpha
Mon, 14 Sep 2026
Ashland to Host Innovation Day Webcast Highlighting Technology Platforms and Growth Opportunities - Quiver Quantitative
Mon, 14 Sep 2026
Ashland leaders will explain how its technologies could grow the business - Stock Titan
Fri, 04 Sep 2026
Ashland Stock Price Forecast. Should You Buy ASH? - StockInvest.us
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 46 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 119.5 (%) |
| Shares Short | 4,260 (K) |
| Shares Short P.Month | 5,690 (K) |
| EPS | 1.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 40.84 |
| Profit Margin | 2.8 % |
| Operating Margin | 11.4 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | 3.9 % |
| Qtrly Rev. Growth | 7.3 % |
| Gross Profit (p.s.) | 13.43 |
| Sales Per Share | 40.18 |
| EBITDA (p.s.) | 7.94 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 291 (M) |
| Levered Free Cash Flow | 269 (M) |
| PE Ratio | 45.67 |
| PEG Ratio | 1.2 |
| Price to Book value | 1.74 |
| Price to Sales | 1.77 |
| Price to Cash Flow | 11.21 |
| Dividend | 0.41 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|